Plain-English translation of NCT07566494 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment target
~25 participants
Started
June 2026
Primary completion
April 2027
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jordan B Branch
National Heart, Lung, and Blood Institute (NHLBI)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.